ACU193

AAIC 2023 – Acumen’s new amyloid approach impresses
EP Vantage
Wed, 07/19/23 - 10:15 am
AAIC
Acumen
Alzheimer's disease
ACU193
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Tue, 02/28/23 - 11:02 am
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies